Inclusion Criteria of Currently Enrolling T-cell Engaging Trials in Multiple Myeloma: Should We Be Focusing on Lines of Prior Therapy
Author Type(s)
Resident/Fellow
Document Type
Article
Publication Date
7-1-2023
DOI
10.1111/bjh.18755
Journal Title
British Journal of Haematology
Department
Medicine
Keywords
Humans, Multiple Myeloma, T-Lymphocytes, Lenalidomide, Thalidomide, Immunotherapy, Adoptive
Disciplines
Medicine and Health Sciences
Recommended Citation
Mohyuddin, G., Kapur, R., & Costa, L. (2023). Inclusion Criteria of Currently Enrolling T-cell Engaging Trials in Multiple Myeloma: Should We Be Focusing on Lines of Prior Therapy. British Journal of Haematology, 202 (1), 1-2. https://doi.org/10.1111/bjh.18755
